BioNexus Gene Lab Corp (NASDAQ:BGLC) traded at $0.37 at close of the session on current trade day and made an upward move of 1.14% on its previous day’s price. Looking at the stock we see that its previous close was $0.36 and the beta (5Y
BioNexus Gene Lab Corp (NASDAQ:BGLC) price on Wednesday, December 04, rose 4.59% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.32. A look at the stock’s price movement, the close in the last trading session was $0.31,
BioNexus Gene Lab Corp (NASDAQ:BGLC) concluded the trading at $0.24 on Wednesday, November 27, with a fall of -1.72% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.24 and 5Y monthly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
